Plasma ctDNA analysis for detection of EGFR T790M mutation in patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (aNSCLC)

被引：15

作者：

Jenkins, S. ^{[1
]}

Yang, J. ^{[2
]}

Ramalingam, S. ^{[3
]}

Yu, K. ^{[4
]}

Patel, S. ^{[5
]}

Weston, S. ^{[1
]}

Lawrance, R. ^{[6
]}

Cantarini, M. ^{[7
]}

Janne, P. ^{[8
]}

Mitsudomi, T. ^{[9
]}

机构：

[1] AstraZeneca, Personalised Healthcare & Biomarkers, Macclesfield, Cheshire, England

[2] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan

[3] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

[4] Roche Mol Syst Inc, Clin Operat, Pleasanton, CA USA

[5] AstraZeneca, Personalised Healthcare & Biomarkers, Oncol Compan Diagnost Unit, Royston, England

[6] AstraZeneca, Biometr & Informat, Macclesfield, Cheshire, England

[7] AstraZeneca, Global Med Dev, Macclesfield, Cheshire, England

[8] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA

[9] Kinki Univ, Sch Med, Thorac Surg, Osaka, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2016年 / 11卷 / 04期

关键词：

D O I：

10.1016/S1556-0864(16)30327-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1340_PR

引用

页码：S153 / S154

页数：2

共 50 条

[1] Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer
Jenkins, Suzanne
Yang, James C-H.
Ramalingam, Suresh S.
Yu, Karen
Patel, Sabina
Weston, Susie
Hodge, Rachel
Cantarini, Mireille
Janne, Pasi A.
Mitsudomi, Tetsuya
Goss, Glenwood D.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (07) : 1061 - 1070
[2] Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
Soejima, Kenzo
Yasuda, Hiroyuki
Hirano, Toshiyuki
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (01) : 31 - 38
[3] An evaluation of aumolertinib for the treatment of EGFR T790M mutation-positive non-small cell lung cancer
Wang, Jingyi
Wu, Lin
EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (06) : 647 - 652
[4] Osimertinib for the Treatment of Metastatic EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
Khozin, Sean
Weinstock, Chana
Blumenthal, Gideon M.
Cheng, Joyce
He, Kun
Zhuang, Luning
Zhao, Hong
Charlab, Rosane
Fan, Ingrid
Keegan, Patricia
Pazdur, Richard
CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2131 - 2135
[5] Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
Skoulidis, Ferdinandos
Papadimitrakopoulou, Vassiliki A.
CLINICAL CANCER RESEARCH, 2017, 23 (03) : 618 - 622
[6] Detection of EGFR T790M in Asia-Pacific patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): Circulating tumour (ct) DNA analysis across 3 platforms
Zhou, C.
Wang, M.
Cheng, Y.
Chen, Y.
Ye, X.
Sun, Y.
Huang, X.
Patel, S.
Chen, Y.
Wu, Y-L.
ANNALS OF ONCOLOGY, 2017, 28
[7] EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
Sonoda, Tomoaki
Nishikawa, Shingo
Sakakibara, Rie
Saiki, Masafumi
Ariyasu, Ryo
Koyama, Junji
Kitazono, Satoru
Yanagitani, Noriko
Horiike, Atsushi
Ohyanagi, Fumiyoshi
Ninomiya, Hironori
Ishikawa, Yuichi
Nishio, Makoto
RESPIRATORY MEDICINE CASE REPORTS, 2018, 24 : 19 - 21
[8] Detection of T790M Mutation in Circulating Free Tumor DNA of Patients with EGFR-Positive Advanced Non-Small Cell Lung Cancer
Veccia, A.
Girlando, S.
Dipasquale, M.
Barbareschi, M.
Caffo, O.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2390 - S2390
[9] Selection of Molecular Techniques for T790M EGFR Mutation Detection in Non-small Cell Lung Cancer
Prim, Nathalie
Quoix, Elisabeth
Beau-Faller, Michele
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) : 1615 - 1616
[10] Real-world osimertinib for EGFR mutation-positive non-small-cell lung cancer with acquired T790M mutation
Imamura, Fumio
Kimura, Madoka
Yano, Yukihiro
Mori, Masahide
Suzuki, Hidekazu
Hirashima, Tomonori
Ihara, Shouichi
Komuta, Kiyoshi
Shiroyama, Takayuki
Nagatomo, Izumi
Kumagai, Toru
FUTURE ONCOLOGY, 2020, 16 (21) : 1537 - 1546

← 1 2 3 4 5 →